BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31050218)

  • 1. Combination of preoperative plasma fibrinogen and AJCC staging improves the accuracy of survival prediction for patients with stage I-II gastric cancer after curative gastrectomy.
    Ding P; Zheng C; Cao G; Gao Z; Lei Y; Deng P; Hou B; Li K
    Cancer Med; 2019 Jun; 8(6):2919-2929. PubMed ID: 31050218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
    Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
    Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
    BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of spleen density in predicting prognosis of patients with gastric cancer after curative gastrectomy].
    Li S; Ma PF; Zhang JL; Cao YH; Liu CY; Zhang XJ; Li ZY; Xue YW; Zhao YZ
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(34):2703-2709. PubMed ID: 34510877
    [No Abstract]   [Full Text] [Related]  

  • 6. Curative resection plus adjuvant chemotherapy for early stage primary gastric non-Hodgkin's lymphoma: a retrospective study with emphasis on prognostic factors and treatment outcome.
    Waisberg J; André EA; Franco MI; Abucham-Neto JZ; Wickbold D; Goffi FS
    Arq Gastroenterol; 2006; 43(1):30-6. PubMed ID: 16699615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
    Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
    Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy.
    Lu J; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX
    Surg Oncol; 2013 Sep; 22(3):167-71. PubMed ID: 23787074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Preoperative Fibrinogen Associated with the Survival Prognosis of Gastric Cancer Patients? A Multi-centered, Propensity Score-Matched Retrospective Study.
    Zhao LY; Zhao YL; Wang JJ; Zhao QD; Yi WQ; Yuan Q; Chen XZ; Li Y; Yang K; Chen XL; Zhang WH; Liu K; Pang HY; Galiullin D; Wang H; Sun LF; Song XH; Zheng JB; Yao XQ; Zhou ZG; Yu PW; Hu JK
    World J Surg; 2020 Jan; 44(1):213-222. PubMed ID: 31637507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor volume as a prognostic factor was superior to the seventh edition of the pT classification in resectable gastric cancer.
    Jiang N; Deng JY; Ding XW; Liu Y; Liang H
    Eur J Surg Oncol; 2015 Mar; 41(3):315-22. PubMed ID: 25601610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a staging system and survival prediction model for advanced gastric cancer patients without adjuvant treatment after curative gastrectomy: A retrospective multicenter cohort study.
    Park KB; Jun KH; Song KY; Chin H; Lee HH
    Int J Surg; 2022 May; 101():106629. PubMed ID: 35460886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of preoperative fibrinogen-to-albumin ratio and postoperative TNM stage (FAR-TNM) predicts the survival in gastric cancer patients after gastrectomy.
    Zhang X; Qiu X; Yin H; Zhao W; Song L; Zhang X; Yang L; Tao M
    Biomarkers; 2023 Dec; 28(8):714-721. PubMed ID: 38059615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.
    Wu XJ; Miao RL; Li ZY; Bu ZD; Zhang LH; Wu AW; Zong XL; Li SX; Shan F; Ji X; Ren H; Ji JF
    Eur J Surg Oncol; 2015 Jul; 41(7):927-33. PubMed ID: 25913059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
    Ojima H; Araki K; Kato T; Okamura K; Manda R; Hirayama I; Hosouchi Y; Nishida Y; Kuwano H
    Anticancer Res; 2006; 26(2B):1385-90. PubMed ID: 16619548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
    Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the impact of tumor deposits on prognosis in gastric cancer and a proposal for their incorporation into the AJCC staging system.
    Chen H; Tang Z; Chen L; Li H; Wang X; Liu F; Sun Y
    Eur J Surg Oncol; 2018 Dec; 44(12):1990-1996. PubMed ID: 30360989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
    Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer.
    Zhang H; Liu H; Shen Z; Lin C; Wang X; Qin J; Qin X; Xu J; Sun Y
    Ann Surg; 2018 Feb; 267(2):311-318. PubMed ID: 27763900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients.
    Cao Y; Liu H; Zhang H; Lin C; Li R; Wu S; Li H; He H; Zhang W; Xu J
    Oncotarget; 2017 Mar; 8(12):20328-20339. PubMed ID: 27780937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.